Live Breaking News & Updates on Resolution differentiation

Stay informed with the latest breaking news from Resolution differentiation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Resolution differentiation and stay connected to the pulse of your community

Recent Microbiome Study Finds that Shoreline Biome Products Differentiate Closely Related Gut Bacteria in Premature Infants


Recent Microbiome Study Finds that Shoreline Biome Products Differentiate Closely Related Gut Bacteria in Premature Infants
Share Article
FARMINGTON, Conn. (PRWEB)
February 18, 2021
Products from Shoreline Biome demonstrated high-resolution tracking of specific bacterial strains in a recent microbiome study, the results of which are being applied to better understand how pathogens and commensals become established in premature infants in neonatal intensive care units (NICU), with the goal of improving outcomes for premature infants.
Shoreline Biome is a microbiome research company based in Farmington that develops tools for characterizing microbiome populations down to the strain level.
The research article, titled "High-Resolution Differentiation of Enteric Bacteria in Premature Infant Fecal Microbiomes Using a Novel rRNA Amplicon," was published February 16, 2021 in mBio. The study describes how Shoreline Biome’s kits and software enable a novel, high-resolution ‘DNA fingerprint’ for bacteria that provides species- and strain-level resolution of the neonatal microbiome. The high-resolution taxonomy obtained from long amplicon sequencing enables the tracking of strains temporally and spatially as microbiomes are established in infants in the hospital environment. “These highly vulnerable infants are at increased risk of developing life-threatening infections.” said Adam Matson, MD (Connecticut Children’s Medical Center and Assistant Professor of Pediatrics and Immunology at UConn Health) “This exciting new approach represents a major technical advancement in the classification of intestinal microbiota and will enable source-tracking of pathogenic and beneficial microbes in the NICU.”

University-of-connecticut , Connecticut , United-states , Farmington , Joerg-graf , Mark-driscoll , Eric-jackson , Adam-matson , Connecticut-children-medical-center , Md-connecticut-children-medical-center , Uconn-health , Shoreline-biome